Related Experiment Videos
The contact-system dependent plasminogen activator from human plasma: identification and characterization
D J Binnema1, G Dooijewaard, J J van Iersel
1Gaubius Institute TNO, Leiden, The Netherlands.
Thrombosis and Haemostasis
|November 30, 1990
Summary
Researchers identified a third plasminogen activator (PA) in human plasma, distinct from t-PA and u-PA. This novel contact-system dependent PA is a 110 kDa polypeptide activated by the contact system, accounting for 30% of plasma PA activity.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Human plasma contains tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA).
- A third, distinct plasminogen activator (PA) activity has been observed in plasma, initiated by contact system triggers.
Purpose of the Study:
- To identify and characterize the third PA present in human plasma.
- To elucidate the properties and activation mechanism of this contact-system dependent PA.
Main Methods:
- Analysis of dextran sulphate euglobulin fractions of human plasma.
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to determine molecular weight.
- Gel chromatography and isoelectric focusing (IEF) to analyze native form and charge.
- Immunoassays using antibodies against t-PA and u-PA.
Main Results:
- A novel 110 kDa single-chain polypeptide was identified as the smallest unit of the third PA.
- Activation of the contact system converts the inactive polypeptide to an active, cleaved form.
- The native form appears as an oligomer (Mr 600,000) with an isoelectric point (pI) of 4.8.
- The active 110 kDa polypeptide contains cryptic u-PA related antigenic determinants, detectable after SDS denaturation.
Conclusions:
- A third, contact-system dependent PA has been identified in human plasma.
- This PA is a distinct entity, not an intrinsic contact system component or simply t-PA or u-PA.
- Its activation pathway and unique properties warrant further investigation in hemostasis and thrombosis.